Mouse Paw Edema Induced by a Novel Bradykinin Agonist and Its Inhibition by B2-Antagonists.

DOI Web Site Web Site Web Site Web Site View 1 Remaining Hide 3 Citations 17 References
  • Ueno Akinori
    Department of Pharmacology, School of Pharmaceutical Sciences, Kitasato University
  • Naraba Hiroaki
    Department of Pharmacology, School of Pharmaceutical Sciences, Kitasato University
  • Oh-ishi Sachiko
    Department of Pharmacology, School of Pharmaceutical Sciences, Kitasato University

Bibliographic Information

Other Title
  • Mouse Paw Edema Induced by a Novel Brad

Search this article

Abstract

A novel non-peptide bradykinin B2-receptor agonist, FR190997 (8-[2, 6-dichloro-3-[N-[(E)4-(N-methylcarbamoyl)cinnamidoacetyl]-N-methylamino]benzyloxy]-2-methyl-4-(2-pyridylmethoxy) quinoline), induced dose-dependent and longer-lasting swelling than bradykinin in the mouse paw. The swelling, peaking around 30 min, was suppressed dose-dependently by intraperitoneal administration of FR173657, a novel non-peptide B2-receptor antagonist. A known B2-antagonist, Hoe 140, also significantly suppressed this edema. The result indicates that the novel B2-agonist FR190997, being more stable than bradykinin, could induce plasma exudation locally in mice via the B2-receptor as a substitute for bradykinin.

Journal

Citations (3)*help

See more

References(17)*help

See more

Keywords

Report a problem

Back to top